Adaptimmune Therapeutics shares owned by Oppenheimer & Co
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Oppenheimer & Co
from 13F filings
Historical chart of Oppenheimer & Co investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Oppenheimer & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $35k | 36k | 0.95 |
| 2024-03-31 | $69k | 44k | 1.58 |
| 2023-09-30 | $53k | 68k | 0.78 |
| 2023-06-30 | $63k | 68k | 0.93 |
| 2020-09-30 | $294k | 37k | 7.98 |